GW 695634
Alternative Names: 695634; GW 695634G; GW-5634; GW-695634; GW678248Latest Information Update: 02 Aug 2023
At a glance
- Originator GlaxoSmithKline
- Class Antiretrovirals
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 31 Dec 2005 Discontinued - Phase-II for HIV-1 infections in USA (PO)
- 22 Aug 2005 Data presented at the 3rd Conference on HIV Pathogenesis and Treatment have been added to the Viral infections therapeutic trials section
- 12 Nov 2004 Data presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2004) have been added to the adverse events , pharmacokinetics and Viral Infections pharmacodynamics section